Schwannome sind benigne periphere Nervenscheidentumoren, welche von den Hüllstrukturen der Nervenzellen, den Schwann-Zellen, ausgehen. Sie können sich peripher, viszeral, intraspinal und intrakranial manifestieren, wobei es sich überwiegend um langsam über Jahre wachsende, solitäre Tumoren handelt, welche sich meist im mittleren Alter manifestieren. Schwannome sind selbst schmerzlos, Symptome kommen erst durch Kompression benachbarter Strukturen zustande. Histologisch werden 5 Subtypen der Schwannome unterschieden, wobei hier eine Übersicht über diese Subklassen gegeben wird. Die im Folgenden geschilderte Patientenvorstellung präsentiert einen Fall eines schnell gewachsenen sog. „ancient“ Schwannoms bei einem 26-jährigen Patienten lumbal.
Abstract
Schwannomas are benign peripheral nerve sheath tumors, originating from sheath structures of nerve cells, the so called Schwann cells. They can grow as peripheral, visceral, intraspinal or intracranial tumours. Schwannomas primarily represent solitary tumors, slowly progressing over years and manifest mostly in the middle age. Schwannomas themselves are painless; symptoms only appear through compression of adjacent structures. Histologically, five subtypes of schwannomas can be distinguished. An overview of these subclasses is given with this case. This presentation displays a case of a rapidly growing “ancient schwannoma” at the lumbar region in a 26-year-old male patient.
Literatur
1 Shah AA, Latoo S, Ahmad I et al. Schwannoma causing resorption of zygomatic arch. J Oral Maxillofac Pathol 2011; 15: 80-84
11 Jahanshahi G, Haghighat A, Azmoodeh F. Intraosseous neurilemmoma of the mandible: report of a rare “ancient” type. Dent Res J (Isfahan) 2011; 8: 150-153
14 Wright BA, Jackson D. Neural tumors of the oral cavity: a review of the spectrum of benign and malignant oral tumors of the oral cavity and jaws. Oral Surg Oral Med Oral Pathol 1980; 49: 509-522
19 Humber CC, Copete MA, Hohn FI. “ancient” schwannoma of upper lip: case report with distinct histologic features and review of the literature. J Oral Maxillofac Surg 2011; 69: e118-e122
20 Zachariades N, Skoura C, Papageorgiou G et al. Giant “ancient” neurilemmoma of the cervical region: report of case. J Oral Maxillofac Surg 2001; 59: 668-672
21 Subhashraj K, Balanand S, Pajaniammalle S. “Ancient” schwannoma arising from mental nerve. A case report and review. Med Oral Patol Oral Cir Bucal 2009; 14: e12-e14
22 López-Carriches C, Baca-Pérez-Bryan R, Montalvo-Montero S. Schwannoma located in the palate: clinical case and literature review. Med Oral Patol Oral Cir Bucal 2009; 14: e465-e468
24 Gainza-Cirauqui ML, Eguía-Del Valle A et al. “ancient” Schwannoma of the hard palate. An uncommon case report and review. J Clin Exp Dent 2013; 5: e62-e65
27 McClatchey AI, Saotome I, Mercer K et al. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev 1998; 12: 1121-1133
28 Giovannini M, Robanus-Maandag E, Niwa-Kawakita M et al. Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes Dev 1999; 13: 978-986
29 McClatchey AI, Saotome I, Mercer K et al. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev 1998; 12: 1121-1133
30 Giovannini M, Robanus-Maandag E, van der Valk M et al. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 2000; 14: 1617-1630
31 Kalamarides M, Niwa-Kawakita M, Leblois H et al. Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes Dev 2002; 16: 1060-1065
32 Trofatter JA, MacCollin MM, Rutter JL et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993; 72: 791-800
33 Rouleau GA, Merel P, Lutchman M et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993; 363: 515-521
34 Turunen O, Wahlstrom T, Vaheri A. Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J Cell Biol 1994; 126: 1445-1453
35 McClatchey AI, Saotome I, Mercer K et al. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev 1998; 12: 1121-1133
37 Kaempchen K, Mielke K, Utermark T et al. Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells. Human Molecular Genetics 2003; 12: 1211-1221
39 Zang KD. Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet 2001; 93: 207-220
40 Evans JJ, Jeun SS, Lee JH et al. Molecular alterations in the neurofibromatosis type2 gene and its protein rarely occurring in meningothelial meningiomas. J Neurosurg 2001; 94: 111-117
42 Trofatter JA, MacCollin MM, Rutter JL et al. A novel moesin-, ezrin-, radixin like gene is a candidate for theneurofibromatosis 2 tumor suppressor. Cell 1993; 75: 826
43 Rouleau GA, Merel P, Lutchman M et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993; 363: 515-521
44 Merel P, Haong-Xuan K, Sanson M et al. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosomes 1995; 13: 211-216
46 Ruttledge MH, Andermann AA, Phelan CM et al. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 1996; 59: 331-342
47 Morrison H, Sherman LS, Legg J et al. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 2001; 15: 968-980
51 Kissil JL, Johnson KC, Eckman MS et al. Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization. J Biol Chem 2002; 277: 10394-10399
52 Rosenbaum C, Kluwe L, Mautner VF et al. Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients. Neurobiol Dis 1998; 5: 55-64
53 Pelton PD, Sherman LS, Rizvi TA et al. Ruffling membrane, stress fiber, cellspreading and proliferation abnormalities in human Schwannoma cells. Oncogene 1998; 17: 2195-2209
